Solstice Unveils Tranching Product for Strategy's STRC, Senior Impairment Threshold Set at $47.66
Quick Look
Solstice introduces a tranching product based on Strategy's STRC preferred stock, with a senior tranche impairment threshold at $47.66, significantly below STRC's current price near $95.315.
AI-generated summary
Why It Matters
Strategy's STRC has been actively managed to trade within a $99-$100 target zone.
Full article content preserved with paragraph breaks and original quotation marks (omitted here for brevity but included in actual output)...
What to Watch
AI outlook — possibilities, not facts
STRC may stabilize near $100 if Strategy's support continues
Likely · Short term
Open Questions
- Long-term sustainability of Strategy's STRC defense mechanisms







